Mergers & Acquisitions ·
Jin Medical completes Kangma equity transfer under VIE acquisition agreement
ZJYLJin Medical International Ltd.
Jin Medical International Ltd. completed the closing of transactions related to its Variable Interest Entity (VIE) structure by finalizing the transfer of 80% equity interest in Zhongjin Kangma Information Technology (Jiangsu) Co., Ltd. from Changzhou Zhongjin Medical Co., Ltd. This completion occurred on October 19, 2026, fulfilling obligations under the VIE Control Master Acquisition Agreement dated September 8, 2026. Consequently, Jin Medical is not required to issue 622,123 Class A ordinary shares that were previously contemplated as substitute consideration if the equity transfer had not been completed by October 31, 2026. The transaction does not result in any additional share issuance or change to the aggregate consideration under the agreement. Jin Medical International Ltd. operates in the medical device and healthcare sector.